General Information of This Antigen (ID: TAR0VQYAS)
Antigen Name
Interferon-stimulated gene 20 kDa protein (ISG20)
Gene Name
ISG20
Gene ID
3669
Synonym
HEM45; Estrogen-regulated transcript 45 protein;Promyelocytic leukemia nuclear body-associated protein ISG20
Sequence
MAGSREVVAMDCEMVGLGPHRESGLARCSLVNVHGAVLYDKFIRPEGEITDYRTRVSGVT
PQHMVGATPFAVARLEILQLLKGKLVVGHDLKHDFQALKEDMSGYTIYDTSTDRLLWREA
KLDHCRRVSLRVLSERLLHKSIQNSLLGHSSVEDARATMELYQISQRIRARRGLPRLAVS
D

    Click to Show/Hide
Family
EPCAM family
Function
Interferon-induced antiviral exoribonuclease that acts on single-stranded RNA and also has minor activity towards single-stranded DNA. Exhibits antiviral activity against RNA viruses including hepatitis C virus (HCV), hepatitis A virus (HAV) and yellow fever virus (YFV) in an exonuclease-dependent manner. May also play additional roles in the maturation of snRNAs and rRNAs, and in ribosome biogenesis.

    Click to Show/Hide
Uniprot Entry
ISG20_HUMAN
HGNC ID
HGNC:6130
KEGG ID
hsa:3669
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens
Anti-CD25 mAb D265A
ADC Name Payload Target Linker ADC Info
Anti-CD25 ADC 12-1 [1]
Anti-CD25 ADC 12-1 payload
Undisclosed
Anti-CD25 ADC 12-1 linker
Anti-CD25 ADC 2-7 [1]
Anti-CD25 ADC 2-7 payload
Undisclosed
Anti-CD25 ADC 2-7 linker
Anti-CD25 ADC 3-4 [1]
Anti-CD25 ADC 3-4 payload
Undisclosed
Anti-CD25 ADC 3-4 linker
Anti-CD25 ADC 4-3 [1]
Anti-CD25 ADC 4-3 payload
Undisclosed
Anti-CD25 ADC 4-3 linker
Anti-CD25 ADC 5-3 [1]
Anti-CD25 ADC 5-3 payload
Undisclosed
Anti-CD25 ADC 5-3 linker
Anti-CD25 ADC 6-2 [1]
Anti-CD25 ADC 6-2 payload
Undisclosed
Anti-CD25 ADC 6-2 linker
Anti-CD25 ADC 7-1 [1]
Anti-CD25 ADC 7-1 payload
Undisclosed
Anti-CD25 ADC 7-1 linker
Anti-CD25 ADC 8-5 [1]
Anti-CD25 ADC 8-5 payload
Undisclosed
Anti-CD25 ADC 8-5 linker
Anti-CD25 ADC 9-4 [1]
Anti-CD25 ADC 9-4 payload
Undisclosed
Anti-CD25 ADC 9-4 linker
Anti-CD25 ADC 10-1 [1]
Anti-CD25 ADC 10-1 payload
Undisclosed
Anti-CD25 ADC 10-1 linker
Anti-CD25 ADC 11-5 [1]
Anti-CD25 ADC 11-5 payload
Undisclosed
Anti-CD25 ADC 11-5 linker
Anti-CD25 ADC 12-3 [1]
Anti-CD25 ADC 12-3 payload
Undisclosed
Anti-CD25 ADC 12-3 linker
Anti-CD25 ADC 13-7 [1]
Anti-CD25 ADC 13-7 payload
Undisclosed
Anti-CD25 ADC 13-7 linker
Anti-CD25 ADC 14-5 [1]
Anti-CD25 ADC 14-5 payload
Undisclosed
Anti-CD25 ADC 14-5 linker
Anti-CD25 ADC 15-5 [1]
Anti-CD25 ADC 15-5 payload
Undisclosed
Anti-CD25 ADC 15-5 linker
Anti-CD25 ADC 16-5 [1]
Anti-CD25 ADC 16-5 payload
Undisclosed
Anti-CD25 ADC 16-5 linker
Anti-CD25 ADC 17-2 [1]
Anti-CD25 ADC 17-2 payload
Undisclosed
Anti-CD25 ADC 17-2 linker
Anti-CD25 ADC 18-3 [1]
Anti-CD25 ADC 18-3 payload
Undisclosed
Anti-CD25 ADC 18-3 linker
Anti-CD25 ADC 19-5 [1]
Anti-CD25 ADC 19-5 payload
Undisclosed
Anti-CD25 ADC 19-5 linker
Anti-CD25 ADC 20-5 [1]
Anti-CD25 ADC 20-5 payload
Undisclosed
Anti-CD25 ADC 20-5 linker
Anti-CD25 ADC 21-5 [1]
Anti-CD25 ADC 21-5 payload
Undisclosed
Anti-CD25 ADC 21-5 linker
Anti-CD25 mAb PC61
ADC Name Payload Target Linker ADC Info
CD25-ADC [2]
SG3199
Human Deoxyribonucleic acid (hDNA)
Mal-PEG8-Val-Ala-PABC
Anti-CD25 mAb RFT5
ADC Name Payload Target Linker ADC Info
RFT5-SMPT-dgA
Deglycosylated ricin A-chain (dgA)
Undisclosed
Succynimidyloxycarbonyl-alpha-methyl-alpha- (2-pyridyl-dithio) toluene (SMPT)
Basiliximab
ADC Name Payload Target Linker ADC Info
Basiliximab sarotalocan [3]
Undisclosed
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
Anti-CD25-IR700 conjugate (Rakuten Medical) [4]
IRDye 700DX
Undisclosed
Undisclosed
References
Ref 1 Phosphate based linkers for intracellular delivery of drug conjugates; 2015-10-08.
Ref 2 CD25-targeted antibody-drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity. J Immunother Cancer. 2020 Sep;8(2):e000860. doi: 10.1136/jitc-2020-000860.
Ref 3 Introduction to basic information on ADC drug Basiliximab sarotalocan.
Ref 4 Rakuten Medical Announces FDA Acceptance of an Investigational New Drug (IND) Application for RM-1995, a Conjugate of IR700 and anti-CD25 Antibody; 15 Dec 2021.